Affiliation:
1. Department of Endocrinology, Affiliated Hospital of Chengde Medical University, 36 Nanyingzi Street, Shuangqiao District, Chengde City, Hebei Province, China
2. Department of Dermatology, Chengdu Fifth People’s Hospital, 33 Ma Shi Street, Wenjiang District, Chengdu City, Sichuan Province, China
3. Department of Endocrinology, Hebei Provincial People’s Hospitall, No. 348, Heping West Road, Xinhua District, Shijiazhuang City, Hebei Province, China
Abstract
Object. L6 cells were cultured to explore the possible mechanism underlying the improvement of insulin resistance by Liraglutide (LR). Methods. Cells were divided into 5 groups—control, high-fat, 10 nmol/L
mmol/L palmitic acid (PA) (10LR), 100 nmol/L
mmol/L PA (100LR), and 1000 nmol/L
mmol/L PA (1000LR). CCK-8 method to detect cell viability, GPO-PAP enzymatic method to detect intracellular triglyceride content, and reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) and western blotting methods to detect fatty acid translocase CD36 (FAT/CD36) and fatty acid binding protein 4 (FABP4) in L6 cells, glucose-regulated protein 78 (GRP78), glucose transporter 4 (GLUT4) expression at the mRNA and protein levels, respectively, were performed. Results. We found that after PA intervention for 24 h, the cell viability decreased significantly; the cell viability of the LR group was higher than that of the high-fat group (
). After PA intervention, compared with those in the high-fat group, GRP-78, FAT/CD36, FABP4 mRNA ((4.36 ± 0.32 vs.
); (
vs.
); (
vs.
),
) and protein ((
vs.
); (
vs.
); (
vs.
), both
) expression decreased in the LR group. The expression levels of GLUT4 mRNA ((
vs.
),
) and protein ((
vs.
),
) increased. Conclusion. Therefore, we conclude that LR can reverse PA-induced cell inactivation and lipid deposition, which may be related to the change in GRP-78, FAT/CD36, FABP4, GLUT4, and other factors.
Funder
Basic Research Project of Chengde Science and Technology Bureau
Subject
General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine